Trial Profile
Clinical Trials Insight: 700034077
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 May 2008
Price :
$35
*
At a glance
- Drugs Dulanermin (Primary) ; Bevacizumab; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 30 May 2008 New trial record.
- 16 May 2008 Interim results will be presented at ASCO in May.